相关实验视频

Updated: Aug 11, 2026

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

在初级骨髓纤维化中LOXL2酶活性的预后意义

Guoqing Lv^1,2,3,4, Wenting Lv⁵

¹Department of Hematology, the First Affiliated Hospital of Xinxiang Medical University, Weihui, Henan Province, China.

|December 10, 2024

概括

类似酸氧化酶2 (LOXL2) 在原发性骨髓纤维化 (PMF) 中升高,并与预后不佳有关. 准LOXL2可能为PMF患者提供新的治疗策略.

科学领域:

血液学血液学血液学
在瘤学瘤学.
分子生物学分子生物学

背景情况:

初级骨髓纤维化 (PMF) 是一种骨髓疾病,其特征是纤维化.
对于PMF病变的分子驱动因素还没有完全理解.

研究的目的:

为了研究基氧化酶样2 (LOXL2) 在初级骨髓纤维化中的作用.
评估LOXL2作为PMF的潜在预后标志物和治疗点.

主要方法:

在PMF患者样本中分析LOXL2mRNA和蛋白质表达.
评估LOXL2酶活性及其与临床特征的相关性.
基因组丰富分析和药物预测分析 (CellMiner).

主要成果:

在PMF患者中,LOXL2 mRNA和血清蛋白水平升高.
高LOXL2酶活性与不良预后得分 (IPSS,DIPSS) 和爆炸百分比增加相关.
确定LOXL2活性作为一个独立的不良预后因素.
LOXL2与细胞外矩阵重塑,炎症和JAK-STAT信号相关.

结论:

LOXL2在原发性髓纤维化病原发生过程中发挥着重要作用.
LOXL2是PMF的潜在预后生物标志物.
LOXL2代表了PMF治疗的有前途的治疗标,其中酶抑制剂被确定为潜在的药物.

更多相关视频

High-throughput Measurement of Plasma Membrane Resealing Efficiency in Mammalian Cells

High-throughput Measurement of Plasma Membrane Resealing Efficiency in Mammalian Cells

Published on: January 7, 2019

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking

Published on: October 23, 2019

相关概念视频

Bone Remodeling

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.